NRX Pharmaceuticals, Inc. short interest in 2026
In 2026, NRX Pharmaceuticals, Inc.'s disclosed short interest ran from 12.56% of shares outstanding on 15 Jan 2026 to 22.57% on 15 Sep 2026, a change of +10.01 percentage points. The year's high was 22.57% on 15 Sep 2026 and its low 7.59% on 31 Mar 2026, averaging 13.99% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.27 days on 15 Sep 2026. Full history: NRX Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 12.56% (15 Jan 2026)
- End of year
- 22.57% (15 Sep 2026)
- Change
- +10.01 pp
- High
- 22.57% (15 Sep 2026)
- Low
- 7.59% (31 Mar 2026)
- Average
- 13.99%
- Highest days to cover
- 16.27 (15 Sep 2026)
- SEC filings marked
- 4
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 12.56% | 1.30 | |
| 30 Jan 2026 | 9.90% | 3.78 | |
| 13 Feb 2026 | 9.56% | 5.37 | |
| 27 Feb 2026 | 8.75% | 4.72 | |
| 13 Mar 2026 | 9.78% | 5.12 | |
| 31 Mar 2026 | 7.59% | 2.35 | 10-K filed |
| 15 Apr 2026 | 9.83% | 4.62 | |
| 30 Apr 2026 | 13.33% | 3.22 | |
| 15 May 2026 | 12.89% | 4.16 | 10-Q filed |
| 29 May 2026 | 13.73% | 3.02 | |
| 15 Jun 2026 | 15.76% | 3.33 | |
| 30 Jun 2026 | 14.89% | 5.36 | |
| 15 Jul 2026 | 17.11% | 7.40 | |
| 31 Jul 2026 | 18.09% | 7.59 | |
| 14 Aug 2026 | 20.03% | 5.78 | 10-Q filed |
| 31 Aug 2026 | 21.47% | 11.69 | results (8-K) |
| 15 Sep 2026 | 22.57% | 16.27 |
See also: NRX Pharmaceuticals, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.